Myo-Inositol vs D-Chiro-Inositol: The 40:1 Ratio Explained
How myo-inositol and D-chiro-inositol (DCI) differ, why they are often combined at a 40:1 ratio, and where the evidence is still mixed.
Updated 2026 · Reviewed by Dr. Brennan Commerford, D.C.
Our Recommendation
Myo-Inositol (in 40:1 ratio with DCI)
Myo-inositol is the predominant inositol form in human tissue; the 40:1 combination pairs it with a small amount of DCI rather than relying on DCI alone.
Myo-Inositol + DCI (40:1) vs D-Chiro-Inositol (DCI) Alone
Myo-Inositol + DCI (40:1)
Pros
- +Pairs myo-inositol with a small amount of DCI at a 40:1 ratio
- +Supplies both inositol forms the body uses
- +Myo-inositol is the primary active form; DCI acts as co-factor
Cons
- -Requires finding a product that delivers both in the correct ratio
- -Higher dose volume (typically 2–4 g myo-inositol + 50–100 mg DCI)
Best For
Those who want both inositol forms in their physiological proportion.
40:1 ratio — see the FAQ below
D-Chiro-Inositol (DCI) Alone
Pros
- +Active co-factor in insulin signaling pathways
- +Involved in insulin-signaling pathways that activate glycogen synthase (PMID 20811656)
- +Lower dose volume than myo-inositol
Cons
- -Ratio-comparison research on DCI alone is limited to a single small trial; see the FAQ below
- -Does not supply myo-inositol, which is the dominant active form
- -Does not reproduce the body's physiological ratio on its own
Best For
Those specifically interested in DCI's role in insulin signaling, used at low doses.
Secondary inositol isomer — used at low doses alongside myo-inositol
Frequently Asked Questions
- Why is the 40:1 ratio important?
- A small randomized trial in women with PCOS used a 40:1 myo-inositol:D-chiro-inositol ratio, which its authors describe as the approximate plasma ratio of the two forms (PMID 31298405); myo-inositol is the predominant form in human tissue. Whether supplementing in that proportion produces a measurable benefit has not been established.
- What dose of myo-inositol is used in studies?
- Most published studies use 2–4 g/day of myo-inositol, often combined with 50–100 mg of D-chiro-inositol to achieve the 40:1 ratio. Doses are typically divided into two administrations.
- Can too much DCI be harmful?
- In a small ratio-comparison trial in women with PCOS, DCI alone and DCI-heavy ratios performed worse than the 40:1 ratio on the outcomes measured (PMID 31298405). That single-study finding is unconfirmed: a 2024 systematic review in that population reported potential benefits from DCI for ovulation while finding the overall evidence limited and inconclusive (PMID 38163998). We believe this needs further study and verification. Talk with your healthcare provider before taking DCI on its own.
Ready to formulate with Myo-Inositol (in 40:1 ratio with DCI)?
Build your personalized formula with research-backed dosing.
Start My FormulaRelated Resources
DCI Alone or 40:1? What the Ratio Research Does and Doesn't Show
Our guide walks through the 40:1 myo-inositol to D-chiro-inositol ratio research, who it was conducted in, and where the evidence is still mixed.
See the Ratio ResearchFormulaForge formulates and sells supplements containing the ingredients discussed on this page. Our formulary recommendations are based on peer-reviewed bioavailability research. All cited studies are independently verifiable.